Population Pharmacokinetics of Glyburide in Patients with Well‐Controlled Diabetes

Author:

Tracewell William G.,Stalker Dennis J.,Maloley Pierre A.,Gallagher Thomas F.,Gwilt Peter R.

Abstract

Study Objectives. To investigate glyburide pharmacokinetics in patients with well‐controlled noninsulin‐dependent diabetes mellitus (NIDDM), and test the hypothesis that intersubject variability in the glyburide dose is due to patient differences in the drug's pharmacokinetics.Methods. Prospective, open‐label study.Setting. University‐affiliated, internal medicine outpatient clinic.Patients. Fifty‐one patients with NIDDM (11 women, 40 men, mean age 56.7 ± 15.3 yrs) receiving oral glyburide and with well‐controlled glycohemoglobin levels 10.0% or below.Intervention. After fasting overnight, patients ingested their regular morning dose of glyburide and then ate breakfast. Blood samples were drawn before dosing and between 0.5–2 hours, 2–5 hours, and 5–10 hours after dosing.Measurements and Main Results. Serum glyburide was assayed by high‐performance liquid chromatography and pharmacokinetics by NONMEM. Glyburide clearance was proportional to weight and greater in older patients (> 60 yrs).Conclusion. Variability in the glyburide dose was not primarily due to intersubject differences in the drug's pharmacokinetics.

Publisher

Wiley

Subject

Pharmacology (medical)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3